NB
Noveome Biotherapeutics, Inc.
SEC filingBiotechnology · Pittsburgh, PA
Amount raised$6.8Msold at filing
Total offering$15M$8.2M still open
Investors in the raise6count reported to the SEC
FiledAug 27, 2026first sale Aug 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael KaufmanDirector
Houman HemmatiDirector
Eric KellerExecutive Officer, Director
Ronald PoropatichDirector
Robert LangerDirector
Patrick WelchExecutive Officer, Director
Larry BrownExecutive Officer
Karin PotokaExecutive Officer
Craig NemiroffDirector
Executive officers, directors and promoters as listed on the Form D.